Properties (56)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:Gavis_Pharmaceuticals
Medius Health |
gptkbp:awards |
Various Industry Awards
|
gptkbp:clinicalTrials |
Yes
|
gptkbp:communityInvolvement |
Yes
|
gptkbp:customerBase |
Hospitals
Patients Pharmacies Healthcare_Providers |
gptkbp:distributionChannels |
Yes
|
gptkbp:employees |
Approximately 1,000
|
gptkbp:financialPerformance |
Strong
|
gptkbp:focus |
Generic_Pharmaceuticals
Over-the-Counter_Products Branded_Pharmaceuticals |
gptkbp:founded |
2003
|
gptkbp:futurePlans |
Strengthen partnerships.
Launch new products. Enhance digital capabilities. Increase R&D investment. Expansion_in_the_US_market. |
gptkbp:globalPresence |
Yes
|
gptkbp:headquarters |
gptkb:Baltimore,_Maryland
|
https://www.w3.org/2000/01/rdf-schema#label |
Lupin Pharmaceuticals USA
|
gptkbp:market |
gptkb:United_States
Regularly |
gptkbp:marketSegment |
Focus on patient needs.
|
gptkbp:mission |
To provide high-quality, affordable medicines.
|
gptkbp:parentCompany |
gptkb:Lupin_Limited
|
gptkbp:partnerships |
Government Agencies
Research Institutions Academic Institutions Various Healthcare Organizations Healthcare_Providers Non-Profit_Organizations |
gptkbp:productionCompany |
Yes
|
gptkbp:productLine |
Antibiotics
Cardiovascular Drugs Diabetes Medications Dermatology Products Oncology Products Respiratory Drugs Central_Nervous_System_Drugs |
gptkbp:regulatoryCompliance |
gptkb:FDA
|
gptkbp:researchAndDevelopment |
Yes
|
gptkbp:subsidiary |
gptkb:Lupin_Limited
|
gptkbp:sustainabilityInitiatives |
Yes
|
gptkbp:values |
Collaboration
Innovation Integrity Respect Excellence Quality |
gptkbp:vision |
To be a leading global pharmaceutical company.
|
gptkbp:website |
www.lupin.com
|